Clariane SE (CHIX:CLARIP) Long-Term Debt: €1,807 Mil (As of Dec. 2025)


CHIX:CLARIP Clariane SE CHIX:CLARIP
63 GF Score
Price €4.13
GF Value €2.47
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Clariane SE Long-Term Debt?

Clariane SE CHIX:CLARIP 63 Long-Term Debt is €1,807 Mil as of Dec. 2025. GuruFocus rates CHIX:CLARIP with a GF Score™ of 63/100 and a GF Value™ of €2.47 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Clariane SE's Long-Term Debt for the quarter that ended in Dec. 2025 was €1,807 Mil.

Clariane SE's quarterly Long-Term Debt increased from Dec. 2024 (€2,977 Mil) to Jun. 2025 (€3,310 Mil) but then declined from Jun. 2025 (€3,310 Mil) to Dec. 2025 (€1,807 Mil).

Clariane SE's annual Long-Term Debt declined from Dec. 2023 (€3,495 Mil) to Dec. 2024 (€2,977 Mil) and declined from Dec. 2024 (€2,977 Mil) to Dec. 2025 (€1,807 Mil).

Clariane SE  (CHIX:CLARIp) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Clariane SE Long-Term Debt Related Terms

Clariane SE Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Clariane SE's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clariane SE Long-Term Debt Chart

Clariane SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,761.48 3,560.26 3,494.58 2,977.43 1,806.75

Clariane SE Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,494.58 3,156.63 2,977.43 3,309.74 1,806.75
CHIX:CLARIP
63GF Score
Clariane SE CHIX:CLARIP
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of €1,807 Mil mean?
Clariane SE (CHIX:CLARIP) has a Long-Term Debt of €1,807 Mil as of Dec. 2025.
Is Clariane SE's Long-Term Debt too high?
Clariane SE's current Long-Term Debt is €1,807 Mil. Overall, Clariane SE has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's Long-Term Debt compare to HCA and THC?
Clariane SE's Long-Term Debt of €1,807 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Clariane SE's current Long-Term Debt is €1,807 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (CHIX:CLARIP) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.47, compared to a current price of €4.13 — trading 67% above its estimated fair value. The current Long-Term Debt is €1,807 Mil. Clariane SE's overall GF Score™ is 63/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Clariane SE (CHIX:CLARIP), the current Long-Term Debt is €1,807 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clariane SE (CHIX:CLARIP) Overvalued in 2026?

Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued. The current stock price of €4.13 is trading 67% above its estimated GF Value™ of €2.47. GuruFocus considers Clariane SE to be Significantly Overvalued.

Key valuation signals for CHIX:CLARIP:

  • Long-Term Debt: €1,807 Mil
  • GF Value™: €2.47 vs. price of €4.13 (67% above fair value)
  • GF Score™: 63/100 with 9 warning signs

No single metric tells the full story. See the CHIX:CLARIP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clariane SE Business Description

Address 21-25, Rue Balzac, Paris, FRA, 75008
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
63GF Score

Get the complete analysis for CHIX:CLARIP

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.13
Price
€2.47
GF Value